Alert: Teva Digihaler

Teva UK Limited has recalled batches of GoResp Digihaler, due to commercial reasons.

The affected batches are:

Batch No	Expiry Date	Pack Size	First Distributed
AGD11A	04/2026	160/4.5mcg (180 dose)	18/07/2023

Batch No	Expiry Date	Pack Size	First Distributed
AGD12A	04/2026	320/9mcg (90 dose)	18/07/2023

Active Pharmaceutical Ingredient: Budesonide/Formoterol Fumarate Dihydrate

The inhalers containing the medicinal product are being withdrawn from the market because the Digihaler App is no longer being supported. There is no product quality issue with the medicine itself.

Healthcare professionals are asked to quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

MHRA alert

Latest news

England & Wales: initial August concession price update

The Department of Health and Social Care has published an initial update to the initial list of August concessions. In this update, there are 48 new prices DDA members can download a fully updated spreadsheet of the Aug

New CD guidance for limited companies

The DDA and the Healthcare Distribution Association (HDA) has published joint guidance on the supply of Controlled Drugs to GP practices constituted as a limited company. In summary, two core regulatory requirements apply: Care regulator registra

Dispensing cross subsidy highlighted in rural GP funding critique

The role of dispensing income as a cross subsidy for rural NHS GP funding has been highlighted in a new paper by a think-tank. Noting the funding challenges of delivering NHS GP services in rural areas, General practice funding in England publ

Alert: Teva Digihaler

Latest news

England & Wales: initial August concession price update

New CD guidance for limited companies

Dispensing cross subsidy highlighted in rural GP funding critique

View all news

Gold Supporters

Follow us

Dispensing Doctors' Association

DDA Best Practice Group

Dispensing Doctors' Association